No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls

Sarven Sabunciyan, Nataniel Mandelberg, Charles S. Rabkin, Robert Yolken, Raphael Viscidi

Research output: Contribution to journalArticlepeer-review

Abstract

New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.

Original languageEnglish (US)
Pages (from-to)134-136
Number of pages3
JournalMolecular and Cellular Probes
Volume25
Issue number2-3
DOIs
StatePublished - Apr 2011

Keywords

  • ELISA
  • Epidemiology
  • Prostate cancer
  • Virus
  • XMRV
  • Xenotropic murine leukemia Virus-related virus

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls'. Together they form a unique fingerprint.

Cite this